Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Reserve a Booth
Exhibitor Resources
Attend
Register Now
Registration Information
Exhibit Hall
Networking Events
Venue & Housing
Visa Letter
AASLD Foundation
AASLD Members
Awards & Honors Gala
Program
Schedule
Speakers
Special Programs
Global Programming
CE Credits
Preliminary Guide
Satellite Symposia
TLM Theaters
Academic Debates
Register Now
Advances in Hepatitis Management
Nov
10
2025
Convention Center: Room 207, Level 2
8:00 AM - 9:30 AM
World Class Speakers
Moderator
Nimy John, MD
University of Florida College of Medicine
Moderator
Ayman A Koteish, MD, FAASLD
AdventHealth Transplant Institute
Description
This session will highlight recent data on therapy for chronic hepatitis D, including real-world effectiveness, safety, and predictors of treatment response. Presentations will explore outcomes across various patient populations.
Journey Maps
Hepatitis
Objectives
Assess real-world effectiveness of hepatitis delta virus (HDV) therapies.
Compare treatment outcomes for hepatitis delta in various patient populations
Identify characteristics associated with virologic response in HDV